BioSpace News Archive

Drug Development

Daré Bioscience Announces Publication in Menopause: The Journal of The North American Menopause Society of Data from Phase 1 Trial of DARE-HRT1

Daré Plans to Advance DARE-HRT1 into Single Phase 3 Efficacy Trial for Treatment of Vasomotor Symptoms (VMS) due to Menopause.

January 26, 2023
·
13 min read
Pharm Country

Onconova Therapeutics Announces Participation in the Channelchek Takeaway Series

Onconova Therapeutics, Inc. today announced their participation in the Channelchek Takeaway Series from the J.P.Morgan Healthcare Conference, to be broadcast Thursday, January 26, starting at 10:00 EST.

January 26, 2023
·
3 min read
Ascletis Announces IND Approval of Oral Viral Polymerase Inhibitor ASC10 for Monkeypox Indication by China NMPA

Ascletis Pharma Inc. (HKEX: 1672, “Ascletis”) announces that the China National Medical Products Administration (NMPA) has approved the Investigational New Drug (IND) application of ASC10 for monkeypox indication.

January 26, 2023
·
3 min read
Pharm Country

Sapience Therapeutics to Present at the Guggenheim Healthcare Talks 2023 Oncology Day

Sapience Therapeutics, Inc. announced today that management will present at the Guggenheim Healthcare Talks 2023 Oncology Day, being held February 8-9, 2023.

January 26, 2023
·
2 min read
Business

Strados Labs Forms Collaboration with Boehringer Ingelheim for its Idiopathic Pulmonary Fibrosis (IPF) Pilot Study

Strados Labs today announced a collaboration with Boehringer Ingelheim to remotely monitor patients using its FDA-cleared pulmonary wearable device in an upcoming idiopathic pulmonary fibrosis (IPF) pilot study.

January 26, 2023
·
2 min read
Business

Pear Therapeutics and BrightView Health Expand Pilot Program to Provide Prescription Digital Therapeutics for the Treatment of Substance Use Disorders

Pear Therapeutics, Inc. announced today the expansion of its collaboration with BrightView Health, an addiction treatment provider that offers evidence-based, outpatient addiction treatment provider that offers evidence-based, outpatient addiction treatment programs.

January 26, 2023
·
15 min read
Policy

Merck Animal Health Receives U.S. FDA Approval of Expanded Indication for BRAVECTO (fluralaner) Chews for Dogs

Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA, announced the U.S. Food and Drug Administration’s approval of an expanded indication for BRAVECTO® Chews for Dogs.

January 26, 2023
·
8 min read
Business

Dynatronics Corporation Reports Second Quarter Results

Dynatronics Corporation today announced that the company will release financial results for its second quarter of fiscal year 2023 on Thursday, February 9, 2023 before the market opens.

January 26, 2023
·
2 min read
BioMidwest

Scripps Health Radiation Therapy Centers Named Patient Safety Center of Excellence by Sun Nuclear

Sun Nuclear, a wholly-owned subsidiary of Mirion Technologies, Inc., announced that it has designated Scripps Health as a Patient Safety Center of Excellence.

January 26, 2023
·
4 min read
BioMidwest

Recursion Releases MolRec, a Compound Intelligence Tool for Drug Discovery, Alongside the Largest of Its Kind Open-Source Dataset During First R&D Day

Recursion announced the public release of MolRec™ - one of its many interactive internal tools to explore the company’s proprietary maps of biology and chemistry.

January 26, 2023
·
7 min read